Race Oncology 2022 Annual Report

Race Oncology 2022 AGM Presentation
Race Oncology 2022 AGM Presentation by CEO Phil Lynch and CSO Dr Daniel Tillett. https://youtu.be/sIgOxKGC6Cg
Race Oncology June 2022 Quarterly Investor Briefing
Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race's June 2022 Quarterly…
Race Oncology 2019 Annual General Meeting Presentation
https://www.youtube.com/embed/camFwooKzNw Overview of Race Oncology’s new “5 path” strategy for the development of Bisantrene. •…